This will be a prospective, non-controlled study using healthy adult volunteers as subjects receiving bilateral proximal humerus intraosseous (IO) vascular access to evaluate the insertion technique and IO infusion flow rates.
When using IO access in the perioperative and OR settings, abduction of the arms to the shoulder level prevents use of the traditional proximal humerus insertion site due to the rotation of the humeral head under the acromion process. An alternate proximal humerus IO insertion technique has been developed to meet the needs of anesthesia patient positioning that uses a slightly more distal insertion site and a superior angle of insertion. However infusion flow rate in the proximal humerus using the anesthesia technique has not been measured. This study is needed to evaluate the anesthesia proximal humerus IO insertion technique to determine if the IO infusion flow rates remain unchanged by the alternate method.
Study Type
INTERVENTIONAL
Allocation
NA
Masking
NONE
Enrollment
5
The arm receiving the IO needle is positioned with the arm abducted to shoulder level (in position required for surgery), with the arm rotated inward, into the optimal position, with the palms faced down. Deeply palpate the humerus until the junction of the humeral shaft and the humeral head, the surgical neck is identified; the insertion site is in the surgical neck. With the 45mm IO needle placed perpendicular to the plane of the skin, the IO needle is inserted into the surgical neck using a slightly superior angle of insertion and the needle is inserted to the hub. The stylet will be removed and an EZ-Connect primed with 2% preservative-free lidocaine will be attached to the catheter hub. Aspirate return will be attempted to confirm needle placement within the medullary cavity.
Bulverde-Spring Branch EMS
Spring Branch, Texas, United States
Intraosseous Infusion Flow rate
The primary objective of the study is to evaluate the infusion flow rates attainable when using the anesthesia approach to establish proximal humerus IO vascular access. The primary endpoints will be the infusion flow rate obtained at each tested infusion pressure, including gravity, 100 mmHg, 200 mmHg, and 300 mmHg.
Time frame: Day 1 after establishing proximal humerus IO vascular access
Evaluate relationship between IO and peripheral venous blood
The secondary objectives for this study are to evaluate the relationship between IO and peripheral venous blood when used for routine laboratory testing. Secondary Endpoints will include results of routine blood analysis.
Time frame: Day 1 after establishing proximal humerus IO vascular access and peripheral venous access
The secondary objective for this study is to evaluate the infusion pathway from the proximal humerus to the heart.
The secondary objectives for this study is to evaluate the infusion pathway from the proximal humerus. Secondary Endpoint will be time in seconds for fluid delivery from the proximal humerus to the heart, using visualization of contrast injection under fluoroscopy.
Time frame: Day 1 after establishing proximal humerus intraosseous vascular access
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.